Publication Cover
Synthetic Communications
An International Journal for Rapid Communication of Synthetic Organic Chemistry
Volume 52, 2022 - Issue 5
350
Views
3
CrossRef citations to date
0
Altmetric
Articles

A novel total synthesis of (+)-brazilin

, , , &
Pages 724-732 | Received 27 Jan 2022, Published online: 06 Mar 2022
 

Abstract

Brazilin, structurally composed of a chroman skeleton cis-fused with a 2,3-dihydro-1H-indene unit, is an important active component of the famous traditional Chinese medicine, Caesalpinia sappan L., which belongs to homoisoflavonoid natural products. Brazilin possesses a series of outstanding bioactivities, such as antitumor, anti-inflammatory, hypoglycemic, antibacterial, hepatoprotective activities, which attracts the great interest of synthetic chemists and medicinal chemists. In almost all of the recently published approaches to brazilin, dihydroxylation using highly toxic osmium reagents was employed to construct chiral hydroxyl at C-3 position. Herein, we described a total synthesis of (+)-brazilin from 3,4-dimethoxybenzyl alcohol via overall nine steps, including oxidation using air to prepare hydroxyl at C-3 position, a lipase-catalyzed desymmetrization to establish chiral hydroxyl at the C-3 position, and a trifluoroacetic acid-catalyzed one-pot intramolecular tandem Prins/Friedel-Crafts reaction to construct the cis-fused chromane and indane framework.

Graphical Abstract

Acknowledgments

We thank the National Science Foundation of China (82003810) for the funding support.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.